Kanchanar guggullu 500mg 6AM 6PM MADHUMEHA NASHINI GULLIKKA 1TAB BAD BEFORE FOOD Balaguluchyadi kashayam 15ml with 45ml water BD BEFORE FOOD METFORMIN 250MG +GLIMEPRIDE 0.25MG BD AFTER FOOD Amrtamehari churna 3g bd after food Arogyavardhini vati 1 tab BD

Reading File
Asking for Preferences

Mode of action of each drug according to ayurvedia and modern science

Finding Sources
Searching the Web

Kanchanar guggulu mode of action ayurveda modern pharmacology

Searching the Web

Balaguluchyadi kashayam pharmacological action ayurveda diabetes

Finding Sources
Searching the Web

Amrtamehari churna Arogyavardhini vati Madhumeha nashini mode of action pharmacology

Searching the Web

Metformin Glimepiride mechanism of action pharmacology

Reading Web Page

https://ask-ayurveda.com/wiki/article/715-kanchnar-guggulu

Searching PubMed

Amritamehari churna antidiabetic mechanism

Here is the complete mode of action for each drug in this prescription - both Ayurvedic and modern pharmacological perspectives:

Mode of Action: Prescription Drug Analysis

This prescription treats Madhumeha (Prameha) / Type 2 Diabetes Mellitus using a combined Ayurvedic + allopathic approach.

1. Kanchanar Guggulu 500 mg (6 AM & 6 PM)

Ayurvedic Mode of Action

  • Dosha action: Balances Kapha dosha - the primary dosha aggravated in Prameha/Madhumeha. Reduces Kapha's heavy, sticky, and obstructive qualities in channels (Srotas)
  • Rasa (taste): Kashaya (astringent), Tikta (bitter) - both are Kapha-pacifying
  • Virya: Ushna (hot potency) - liquefies and mobilizes Ama (metabolic toxins), promotes its outward movement
  • Karma: Kaphahara, Lekhana (scraping action that removes excess deposits), Srotoshodhana (channel-clearing)
  • Specific action: Acts on the lymphatic system and Meda dhatu (fat tissue) - relevant in obesity-linked diabetes. The Lekhana property scrapes fat deposits and reduces Kapha-related tissue stagnation

Modern Pharmacological Action

  • Bauhinia variegata (Kanchnar bark): Contains flavonoids (kaempferol, quercetin) and triterpenoids - modulate immune responses, anti-inflammatory via cytokine suppression
  • Commiphora mukul (Guggulu resin): Contains guggulsterones - inhibit NF-κB pathway, reducing inflammatory cytokines (TNF-α, IL-6). Also shown to lower lipids (LDL, triglycerides) by upregulating bile acid synthesis
  • Combined effect: Reduces insulin resistance indirectly through anti-inflammatory and hypolipidemic actions, which are key contributors to Type 2 DM pathophysiology

2. Madhumeha Nashini Gulika 1 Tab BD (Before Food)

Ayurvedic Mode of Action

  • Name itself is diagnostic: "Madhumeha Nashini" = destroyer of Madhumeha (honey-like urine / diabetes)
  • Classical indication: Directly indicated for all 20 types of Prameha, especially Madhumeha (which correlates to Type 2 DM)
  • Action: Tikta (bitter) and Kashaya (astringent) rasas in its ingredients reduce Kleda (excessive moisture/fluidity), dry up excess urine, and correct Medodushti (vitiation of fat tissue)
  • Deepana-Pachana: Kindles digestive fire (Agni), destroys Ama, and restores proper tissue metabolism (Dhatu Poshana)
  • Herbs commonly included: Guduchi, Haridra, Amalaki, Shilajit, Vijaysar, Jambu beej - each with specific anti-prameha action

Modern Pharmacological Action

  • Alpha-glucosidase inhibition: Bitter herbs delay carbohydrate absorption in the gut
  • Insulin secretagogue effect: Some components (Shilajit, Vijaysar) may stimulate pancreatic beta-cell activity
  • Antioxidant action: Reduces oxidative stress on pancreatic cells
  • Improvement of insulin sensitivity: Guduchi (Tinospora cordifolia) shown to enhance peripheral glucose uptake
  • Exact composition varies by manufacturer - the combined action targets postprandial hyperglycemia through multiple mechanisms

3. Balaguluchyadi Kashayam 15 ml + 45 ml Water BD (Before Food)

Ayurvedic Mode of Action

  • Three-level action (Dosha-Dhatu-Mala):
    • Dosha level: Pacifies aggravated Vata (pain, neuropathy, stiffness) and Pitta (burning, inflammation) - addresses diabetic neuropathy and peripheral inflammation
    • Dhatu level: Nourishes Asthi dhatu (bone), Mamsa dhatu (muscle), purifies Rakta dhatu (blood) - corrects tissue malnutrition seen in diabetes
    • Mala level: Promotes elimination of metabolic waste, prevents Ama accumulation in channels
  • Key ingredient - Guduchi (Tinospora cordifolia): Premier Rasayana (rejuvenating), Jwaraghna (fever-reducing), Medhya (intellect-promoting), Tridoshahara
  • Bala (Sida cordifolia): Balya (strength-giving), Vata-pacifying - supports muscle and nerve tissue in diabetic patients

Modern Pharmacological Action

  • Guduchi (Tinospora cordifolia):
    • Contains berberine, tinosporin, palmatine - reduce blood glucose by enhancing insulin signaling
    • Immunomodulatory: Activates macrophages, increases protective cytokines
    • Hepatoprotective: Reduces lipid peroxidation in liver
  • Anti-inflammatory pathway: Formulation inhibits COX-2 and LOX enzymes, reducing prostaglandin synthesis - addresses diabetic inflammatory complications
  • Antioxidant action: Scavenges free radicals, reduces glycation end-products (relevant in diabetic vascular damage)
  • Detoxification: Punarnava (Boerhavia diffusa) in the formulation promotes renal excretion of waste metabolites

4. Metformin 250 mg + Glimepiride 0.25 mg BD (After Food)

Metformin - Modern Mechanism of Action

  • Primary action - Reduces hepatic glucose output: Activates AMPK (AMP-activated protein kinase) in the liver → inhibits gluconeogenesis (new glucose production from glycerol/amino acids)
  • Secondary action: Inhibits mitochondrial Complex I and Complex IV → reduces glycerol-3-phosphate → less substrate for gluconeogenesis
  • Peripheral effect: Improves insulin sensitivity in muscle and fat cells - enhances glucose uptake via GLUT-4 transporter translocation
  • Gut effect: Reduces glucose absorption from intestine; may increase GLP-1 levels
  • Does NOT cause hypoglycemia as it does not stimulate insulin secretion directly
  • Weight-neutral to weight-reducing

Glimepiride - Modern Mechanism of Action

  • Class: 3rd generation sulfonylurea
  • Mechanism: Binds to SUR1 subunit of ATP-sensitive K⁺ (KATP) channels on pancreatic beta cells → closes K⁺ channels → membrane depolarization → Ca²⁺ influx via voltage-gated channels → triggers insulin granule release (exocytosis)
  • Extra-pancreatic effects: Also improves peripheral insulin sensitivity by increasing GLUT-4 expression in muscle/fat
  • Advantage over older sulfonylureas: Lower risk of hypoglycemia; does not suppress the normal insulin suppression response to hypoglycemia

Ayurvedic Correlation

  • Metformin's action parallels Tikta rasa (bitter taste) herbs - reduce Kleda, dry up excess moisture, and improve cellular metabolism
  • Glimepiride's stimulant action on pancreatic secretion correlates with Deepana (digestive-stimulant) and Pachana herbs in Ayurveda

5. Amrtamehari Churna 3 g BD (After Food)

Ayurvedic Mode of Action

  • "Amrita" = immortal/Guduchi; "Mehari" = reduces Prameha (diabetes)
  • Primary ingredients typically include: Guduchi (Tinospora cordifolia), Haridra (Curcumin), Amalaki (Emblica officinalis), Shilajit, Neem
  • Rasa: Tikta (bitter) and Kashaya (astringent) - the two most important tastes for managing Prameha
  • Action on Prameha: Corrects Medas (fat), Kleda (moisture), Mootra (urine) abnormalities - the three core pathological factors in Madhumeha
  • Rasayana action: Rejuvenates cells, improves Ojus (vitality/immunity), counters the debilitating effects of chronic hyperglycemia
  • Agni deepana: Improves enzymatic digestion, clears Ama from Medovaha and Mutravaha srotas

Modern Pharmacological Action

  • Guduchi: Berberine content activates AMPK → similar to Metformin pathway; also stimulates GLP-1 secretion
  • Haridra (Curcumin): Inhibits NF-κB → reduces chronic low-grade inflammation (central to T2DM pathology); improves beta-cell function; inhibits alpha-glucosidase
  • Amalaki (Amla): Rich in Vitamin C and tannins - strong antioxidant; inhibits AGEs (advanced glycation end-products); mild alpha-glucosidase inhibitor
  • Shilajit (if present): Contains fulvic acid - improves mitochondrial energy metabolism; enhances insulin receptor sensitivity
  • Combined synergistic effect: Multi-target approach addressing insulin resistance, oxidative stress, inflammation, and glucose absorption simultaneously

6. Arogyavardhini Vati 1 Tab BD

Ayurvedic Mode of Action

  • Name meaning: "Arogya" = health; "Vardhini" = enhancer - literally "health enhancer"
  • Classical indication: Primarily Yakrit vikara (liver disorders), Kustha (skin disorders), and Medoroga (obesity/lipid disorders) - all closely linked to diabetes pathology
  • Ingredients: Shuddha Parada (purified mercury), Shuddha Gandhaka (sulfur), Loha bhasma, Abhrak bhasma, Tamra bhasma, Triphala, Katuki, Shilajit, Guggulu - a Rasaushadhi (herbo-mineral)
  • Primary action:
    • Yakrit uttejaka (liver stimulant): Enhances hepatic detoxification - directly relevant as the liver is the primary organ for glucose homeostasis
    • Deepana-Pachana: Strong digestive fire enhancement, destroys Ama
    • Lekhana: Scrapes and clears Meda dhatu (fat tissue stagnation), reduces Kapha
    • Srotoshodhana: Clears Medovaha srotas (fat channels) and Mutravaha srotas (urinary channels)

Modern Pharmacological Action

  • Katuki (Picrorhiza kurroa): Strongly hepatoprotective; stimulates bile production → improves fat metabolism and liver's role in glucose homeostasis
  • Triphala (Haritaki, Bibhitaki, Amalaki): Antioxidant, reduces oxidative hepatic stress; mild laxative action promotes toxin elimination
  • Loha bhasma (Iron calx): Corrects iron-deficiency states that impair glucose metabolism; may improve hemoglobin (relevant for HbA1c monitoring)
  • Guggulsterones (from Guggulu): NF-κB inhibition, lipid-lowering - synergistic with Kanchanar Guggulu
  • Shilajit: Fulvic acid enhances mitochondrial function; anti-fatigue; improves cellular energy utilization
  • Liver-centric mechanism: By optimizing hepatic function, reduces hepatic glucose output (same target as Metformin) through the Ayurvedic approach

Summary Table

DrugAyurvedic Core ActionModern Core Mechanism
Kanchanar GugguluKapha-hara, Lekhana, Meda-reducingNF-κB inhibition, anti-inflammatory, lipid-lowering
Madhumeha Nashini GulikaKleda-hara, PramehaghnaAlpha-glucosidase inhibition, insulin secretagogue
Balaguluchyadi KashayamVata-Pitta pacification, RasayanaCOX-2/LOX inhibition, immunomodulation, neuroprotection
Metformin 250 mg(Allopathic) Tikta karma correlationAMPK activation → reduces hepatic gluconeogenesis
Glimepiride 0.25 mg(Allopathic) Deepana correlationKATP channel closure → insulin secretion from beta cells
Amrtamehari ChurnaPramehaghna, Rasayana, Agni deepanaAMPK activation, NF-κB inhibition, alpha-glucosidase inhibition, antioxidant
Arogyavardhini VatiYakrit uttejaka, Lekhana, Deepana-PachanaHepatoprotection, lipid metabolism, reduces hepatic glucose output

Clinical note: This is an integrative prescription combining classical Ayurvedic anti-diabetic formulations with low-dose allopathic therapy (Metformin + Glimepiride). The Ayurvedic medicines largely work through multi-target, slow-onset mechanisms addressing the root pathology (Dushta Meda, impaired Agni, Ama accumulation), while the allopathic drugs provide direct, fast-acting glycemic control. Together they address insulin resistance, hepatic glucose output, beta-cell stimulation, gut absorption, oxidative stress, and inflammation - covering the full spectrum of Type 2 DM pathophysiology.

Search for clinical evidence on combined Ayurvedic-allopathic diabetes protocols

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

Hh

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.